Mrs. Tiffany Marie Rollins, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 157 N Paiute Reservation Dr., Kanosh, UT 84637 Phone: 435-759-2610 Fax: 435-759-2608 |
News Archive
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Canada and Europe for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.
TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ophthalmology, announced today that results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 will be presented at the annual meeting of the American Society of Clinical Oncology on June 5-7, 2010 in Chicago, IL.
In a recent medRxiv* preprint paper, Dr. L. Miguel Martins and colleagues from the University of Cambridge investigate the links between neurodegeneration and COVID-19.
Continua Health Alliance, an international organization of leading health care and technology companies, the European Telecommunications Standards Institute (ETSI), responsible for standardization of ICT within Europe, and Integrating the Healthcare Enterprise Europe (IHE-Europe) today announced receipt of funding from the European Commission (EC) for a 12-month project called Smart Personal Health.
Researchers at Lund University in Sweden have discovered a direct link between the protein aggregation in nerve cells that is typical for neurodegenerative diseases, and the regulation of gene expression in Huntington's disease.
› Verified 1 days ago